• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
74,833.50 224.52
( 0.30%)
Global Indices
Nasdaq
49,714.12 -67.45
(-0.14%)
Dow Jones
7,466.35 44.39
(0.60%)
Hang Seng
63,198.64 456.07
(0.73%)
Nikkei 225
10,300.99 35.67
(0.35%)
Forex
USD-INR
95.60 0.47
(0.49%)
EUR-INR
112.29 0.30
(0.26%)
GBP-INR
129.50 0.02
(0.02%)
JPY-INR
0.61 0.00
(0.19%)

EQUITY - MARKET SCREENER

Sunrest Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
91669
INE0PLZ01012
36.3585943
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNREST
16.31
32.61
EPS(TTM)
Face Value()
Div & Yield %
2.33
10
0
 

CEAT consolidated net profit rises 145.10% in the March 2026 quarter
Apr 29,2026
Net profit of CEAT rose 145.10% to Rs 243.85 crore in the quarter ended March 2026 as against Rs 99.49 crore during the previous quarter ended March 2025. Sales rose 23.34% to Rs 4218.89 crore in the quarter ended March 2026 as against Rs 3420.62 crore during the previous quarter ended March 2025.

For the full year,net profit rose 47.69% to Rs 698.02 crore in the year ended March 2026 as against Rs 472.64 crore during the previous year ended March 2025. Sales rose 18.61% to Rs 15678.00 crore in the year ended March 2026 as against Rs 13217.87 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales4218.893420.62 23 15678.0013217.87 19
OPM %14.0511.35 -13.0611.15 -
PBDT533.82318.20 68 1728.961213.90 42
PBT349.76165.88 111 1031.54651.21 58
NP243.8599.49 145 698.02472.64 48